These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 7867143)

  • 1. Vaccination against typhoid fever: present status.
    Ivanoff B; Levine MM; Lambert PH
    Bull World Health Organ; 1994; 72(6):957-71. PubMed ID: 7867143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current status of typhoid vaccine development and clinical trials with typhoid vaccines.
    Levine MM; Tacket CO; Herrington D; Losonsky G; Murphy J; Ferreccio C
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):459-69. PubMed ID: 3064323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia.
    Acosta CJ; Galindo CM; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Park JK; Park E; Koo H; Wang XY; Abu-Elyazeed R; Ali M; Albert MJ; Ivanoff B; Pang T; Xu ZY; Clemens JD
    J Health Popul Nutr; 2004 Sep; 22(3):240-5. PubMed ID: 15609776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial enteric infections and vaccine development.
    Holmgren J; Svennerholm AM
    Gastroenterol Clin North Am; 1992 Jun; 21(2):283-302. PubMed ID: 1512046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression.
    Tacket CO; Levine MM
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S20-3. PubMed ID: 17582563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.
    Simanjuntak CH; Paleologo FP; Punjabi NH; Darmowigoto R; Soeprawoto ; Totosudirjo H; Haryanto P; Suprijanto E; Witham ND; Hoffman SL
    Lancet; 1991 Oct; 338(8774):1055-9. PubMed ID: 1681365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a live oral typhoid vaccine in human volunteers.
    Hornick RB; DuPont HL; Levine MM; Gilman RH; Woodward WE; Snyder MJ; Woodward TE
    Dev Biol Stand; 1976; 33():89-92. PubMed ID: 782976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New generation typhoid vaccines: an effective preventive strategy to control typhoid fever in developing countries.
    Verma R; Bairwa M; Chawla S; Prinja S; Rajput M
    Hum Vaccin; 2011 Aug; 7(8):883-5. PubMed ID: 21791973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Sur D; Ochiai RL; Bhattacharya SK; Ganguly NK; Ali M; Manna B; Dutta S; Donner A; Kanungo S; Park JK; Puri MK; Kim DR; Dutta D; Bhaduri B; Acosta CJ; Clemens JD
    N Engl J Med; 2009 Jul; 361(4):335-44. PubMed ID: 19625715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vaccination against diarrheal diseases and typhoid fever. Current status and prospects].
    Ivanoff B; Neira M
    Ann Med Interne (Paris); 1998 Oct; 149(6):340-50. PubMed ID: 9853044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines against typhoid fever.
    Guzman CA; Borsutzky S; Griot-Wenk M; Metcalfe IC; Pearman J; Collioud A; Favre D; Dietrich G
    Vaccine; 2006 May; 24(18):3804-11. PubMed ID: 16278037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ineffectiveness of an oral killed typhoid vaccine in a field trial.
    Chuttani CS; Prakash K; Vergese A; Gupta P; Chawla RK; Grover V; Agarwal DS
    Bull World Health Organ; 1973 Jun; 48(6):754-5. PubMed ID: 4594320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of oral killed typhoid vaccine.
    Chuttani CS; Prakash K; Vergese A; Sharma U; Singha P; Ray BG
    Bull World Health Organ; 1971; 45(4):445-50. PubMed ID: 4948415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population impact of Vi capsular polysaccharide vaccine.
    Khan MI; Ochiai RL; Clemens JD
    Expert Rev Vaccines; 2010 May; 9(5):485-96. PubMed ID: 20450323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M-01ZH09, an oral live attenuated Salmonella enterica serovar Typhi vaccine for the prevention of typhoid fever.
    Jain SK
    Curr Opin Mol Ther; 2009 Oct; 11(5):565-71. PubMed ID: 19806505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and design.
    Acosta CJ; Galindo CM; Ali M; Elyazeed RA; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Jin Y; Park JK; Lee H; Puri MK; Ivanoff B; Agtini MD; Soeharno R; Simanjuntak CH; Punjabi NH; Canh DG; Sur D; Nizami Q; Manna B; Bai-qing D; Anh DD; Honghui Y; Bhattacharya SK; Bhutta Z; Trach DD; Xu ZY; Pang T; Donner A; Clemens JD
    Trop Med Int Health; 2005 Dec; 10(12):1219-28. PubMed ID: 16359401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of Typhim Vi vaccine in a postmarketing observational study.
    Marcus LC; Froeschle JE; Hill DR; Wolfe MS; Maus D; Connor B; Acosta AM; Rensimer ER; Roberts A; Dardick K
    J Travel Med; 2007; 14(6):386-91. PubMed ID: 17995534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.